2024中国整合肿瘤学大会国际专场(二)
日期:2024年11月16日
地点:西安国际会展中心会议楼二层202会议室
时间 | 题目 | 讲者 | 单位 |
---|---|---|---|
13:30-13:45 |
EuraCan, the EU Funded Activity About Rare Cancers |
Matti Aapro | Sharing Progress in Cancer Care |
13:45-14:00 |
Cancer Control in Canada: Policy, Practice and Outcomes - Strengths and Challenges |
Simon Sutcliffe | Two Worlds Cancer Collaboration |
14:00-14:15 |
Primary Prevention of Gastric Cancer in China |
李文庆 | 北京大学肿瘤医院 |
14:15-14:30 |
European “Beating Cancer” Plan and Its Impact on Cancer Care in Bulgaria |
Jasmina Koeva-Balabanova | Bulgarian Alliance for Precision and Personalized Medicine |
14:30-14:40 |
Discussion |
时间 | 题目 | 讲者 | 单位 |
---|---|---|---|
14:40-14:55 |
LDCT Lung Cancer Screening: A Comparative Study Between China and Northern Europe |
Geertruida H. de Bock | University Medical Center Groningen |
14:55-15:10 |
Perioperative IO Treatment of Locally Advanced NSCLC |
吴楠 | 北京大学肿瘤医院 |
15:10-15:25 |
Sex Differences in Lung Cancer: An Australian Perspective |
Xueqin Yu | The University of Sydney |
15:25-15:40 |
Antibody-Drug Conjugates (ADCs) in Lung Cancer |
AU Siu-Kie | Hong Kong Adventist Hospital Oncology Centre |
15:40-15:50 |
Discussion |
时间 | 题目 | 讲者 | 单位 |
---|---|---|---|
15:50-16:05 |
Insights from the ESMO-CoCARE Study on COVID-19 in Asian Cancer Patients Cohort |
Syed MA Hussain | Bangabandhu Sheikh Mujib Medical University |
16:05-16:20 |
Legal Protections and Ethical Considerations for Integrating AI in Holistic Cancer Care |
Naoufal Louati | Mohammed V University of Rabat |
16:20-16:35 |
Reabilitation of oncologucal patients in Kazakhstan |
Aigul Shinbolatova | 哈萨克斯坦肿瘤放射研究院 |
16:35-16:50 |
Six-and-Twelve Model vs. Up-to-Seven Criteria for TACE-Treated HCC: Which Should We Choose? |
韩国宏 | 西安国际医学中心医院 |
16:50-17:00 |
Discussion |